Furthermore, IL-1β induces IL-6 production by transglutaminase 2- (TG2-) expressing MCF-7 cells through NF-κB-, PI3K-, and JNK-dependent mechanisms, ultimately increasing the stem-cell-like phenotype of cancer cells associated with drug resistance [123]. This evidence concerns the gene TGM2 and cancer.